title: CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
abstract: Susceptibility to Graves' disease (GD) is determined by environmental and genetic factors. The genetic susceptibility to GD is conferred by genes in the human leukocyte antigen (HLA), and several other genes unlinked to HLA are thought to contribute to the development of GD. Three recent papers described the association of GD with the CTLA-4 gene. CTLA-4 is a candidate gene for T-cell mediated autoimmune diseases because it is a negative regulator of T-cell proliferation. As CTLA-4 association with GD may be influenced by the racial composition of the population, it is important to study it in other ethnic groups. We investigated the distribution of CTLA-4 gene polymorphism in 153 Japanese patients with GD (35 males and 118 females) and 200 controls (96 males and 104 females). An A/G transition at position 49 of exon 1 was analyzed by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The distribution of genotype frequencies differs between GD and controls (chi2 = 9.46, 2 degrees of freedom, p < 0.01). The presence of at least one G allele (GG or AG) conferred an odds ratio of 2.64 (95% CI = 1.92-3.36). The present study supported the association of the CTLA-4 gene with GD in Japanese and showed that the CTLA4 gene could be one of the non-HLA linked susceptibility genes for GD.
authors.affiliation: Department of Medicine, Nerima General Hospital, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Yanagawa
authors.forename: M
authors.initials: M
authors.lastname: Taniyama
authors.forename: S
authors.initials: S
authors.lastname: Enomoto
authors.forename: K
authors.initials: K
authors.lastname: Gomi
authors.forename: H
authors.initials: H
authors.lastname: Maruyama
authors.forename: Y
authors.initials: Y
authors.lastname: Ban
authors.forename: T
authors.initials: T
authors.lastname: Saruta
mesh_terms: D000069594:Abatacept; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000235:genetics*; D060908:CTLA-4 Antigen; D003627:Data Interpretation, Statistical; D005260:Female; D005787:Gene Frequency; D005796:Genes / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006111:Graves Disease / Q000453:epidemiology / Q000235:genetics*; D006801:Humans; D018796:Immunoconjugates; D007564:Japan / Q000453:epidemiology; D008297:Male; D011110:Polymorphism, Genetic; D012737:Sex Factors
chemical_list: D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D018796:Immunoconjugates; D000069594:Abatacept